Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Antifungal agents prepared at Pola

Jan. 5, 1998

Anti-MRSA agents prepared at Bristol-Myers Squibb

Jan. 2, 1998

New antifungals from Lilly

Jan. 2, 1998

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

New antifungals disclosed by Schering-Plough

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Aronex/Ferrer seek approval of Nyotran in Spain

Dec. 29, 1997

Lidak submits NDA for Lidakol

Dec. 29, 1997

SS Pharm. patents new antifungal agents

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...